These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36096019)

  • 21. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
    Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
    Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer.
    Baqar AR; Wilkins S; Wang W; Oliva K; McMurrick P
    BMC Cancer; 2020 Aug; 20(1):762. PubMed ID: 32795292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients.
    Li W; Shao X; Ma F; Wang B; Xue L; Hu H; Kang W; Xiong J; Tian Y
    Oncol Res Treat; 2023; 46(7-8):287-295. PubMed ID: 37302386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.
    John BJ; Naik P; Ironside A; Davidson BR; Fusai G; Gillmore R; Watkins J; Rahman SH
    HPB (Oxford); 2013 Sep; 15(9):674-80. PubMed ID: 23458477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms.
    Gao B; Zhou D; Qian X; Jiang Y; Liu Z; Zhang W; Wang W
    Front Endocrinol (Lausanne); 2021; 12():613755. PubMed ID: 33746899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
    Li HJ; Chen YT; Yuan SQ
    Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.
    Kang MJ; Jang JY; Chang YR; Kwon W; Jung W; Kim SW
    Ann Surg Oncol; 2014 May; 21(5):1545-51. PubMed ID: 24419758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma.
    Liu ZQ; Xiao ZW; Luo GP; Liu L; Liu C; Xu J; Long J; Ni QX; Yu XJ
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):634-41. PubMed ID: 25475867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio.
    Shinde A; Horne ZD; Li R; Glaser S; Massarelli E; Koczywas M; Erhunmwunsee L; Reckamp KL; Weksler B; Salgia R; Beriwal S; Amini A
    Lung Cancer; 2019 Jul; 133():136-143. PubMed ID: 31200820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
    Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
    Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
    Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
    Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic ductal adenocarcinoma (PDAC) regional nodal disease at standard lymphadenectomy: is MRI accurate for identifying node-positive patients?
    Adham S; Ferri M; Lee SY; Larocque N; Alwahbi OA; Ruo L; van der Pol CB
    Eur Radiol; 2023 Sep; 33(9):5976-5983. PubMed ID: 37004569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy.
    Javed AA; Ding D; Baig E; Wright MJ; Teinor JA; Mansoor D; Thompson E; Hruban RH; Narang A; Burns WR; Burkhart RA; Lafaro K; Weiss MJ; Cameron JL; Wolfgang CL; He J
    World J Surg; 2022 Mar; 46(3):667-677. PubMed ID: 34994834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma.
    Pu N; Chen Q; Gan W; Shen Y; Gao S; Habib JR; Yin H; Zhang J; Kinny-Köster B; Cui M; Li J; Dong Y; Nagai M; Liu L; Yu J; Wu W; Lou W
    Adv Ther; 2021 Aug; 38(8):4258-4270. PubMed ID: 34176089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of neoadjuvant therapy regimens on lymph nodes yield in rectal cancer.
    Ray-Offor E; Nagarajan A; Horesh N; Emile SH; Gefen R; Garoufalia Z; Dourado J; Parlade A; Da Silva G; Wexner S
    J Surg Oncol; 2024 Jul; 130(1):125-132. PubMed ID: 38800836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
    Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment.
    Adsay NV; Basturk O; Altinel D; Khanani F; Coban I; Weaver DW; Kooby DA; Sarmiento JM; Staley C
    Mod Pathol; 2009 Jan; 22(1):107-12. PubMed ID: 18820663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.